lobbying_activities: 2642472
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2642472 | d5d4963e-eaac-475c-8bb1-e5a70140fba0 | Q2 | FORBES-TATE | 400976792 | LUNDBECK LLC | 2021 | second_quarter | MED | Issues related to Mental health and Alzheimer's disease research; Issues related to the Food and Drug Administration; Issues related to protected class drug. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-07-17T17:22:53.440000-04:00 |